Delivery Order SPE2DE24DA010-SPE2D625F7NX4
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $49.8K by the Department of Defense's Medical Supply Chain for the delivery of Aveir Leadless Pacemakers. The contract, awarded on August 1, 2025, with an ultimate completion date of August 6, 2025, will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and open competition. The award represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $8,750 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and is not subject to any set-aside designation, indicating full and open competition. The award covers delivery of the AVEIR Leadless Pacemaker to the place...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350.00 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as AVEIR (a reference to Abbott's Aveir Leadless Pacemaker technology), will be performed in Santa Clara, California, and was awarded without a set-aside designation, indicating full and open competition. This...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., through its Abbott Vascular Inc. division, for the delivery of Aveir Leadless Dual Chamber Pacemakers. The $48,700.00 firm fixed price delivery order contract has a completion date of May 5, 2025. Abbott Laboratories Inc. is a large pharmaceutical and medical device manufacturer that has been awarded multiple federal contracts and indefinite delivery/indefinite quantity (IDIQ) vehicles to...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $2,500 delivery order on July 28, 2025, for leadless accessories to support federal healthcare operations. The contract, which carries no set-aside designation and operates under fixed-price pricing with economic price adjustment terms, is funded by the Medical Supply Chain division of the Department of Defense and will be performed in Santa Clara, California. This delivery order represents a continuation of...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order with economic price adjustment totaling $9,500 by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as AVEIR and issued on July 29, 2025, with an ultimate completion date of August 1, 2025, will be performed in Santa Clara, California. This delivery order was awarded without set-aside designation, indicating full and open competition among...
- This is a $31,136.08 firm fixed-price purchase order awarded by the Defense Health Agency to Abbott Laboratories Inc., a global medical device manufacturer, for the supply of pacemakers for cardiac procedures. The award does not have a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. is a subsidiary of the parent company Abbott Laboratories, which has a significant federal contracting history with the Department of Veterans Affairs and Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- This federal contract award was issued by the Medical Supply Chain division of the Defense agency to Abbott Laboratories Inc., a large medical device manufacturer. The $10,568.00 fixed-price delivery order is for the delivery of low voltage pacers and related cardiovascular medical devices. The contract has no set-aside designation, indicating full and open competition. Abbott Laboratories Inc. has been awarded numerous federal contracts by the Department of Veterans Affairs (VA) and Defense...
- This federal contract award, valued at $7,575.00, was made by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a large multinational pharmaceutical and medical device manufacturer. The contract is a delivery order for low voltage pacers and is a fixed price with economic price adjustment. The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories, through its Abbott Vascular Inc. division, is a key supplier of advanced...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F7NX4Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a $18,600 fixed-price delivery order with economic price adjustment for Aveir Leadless Pacemakers, with an ultimate completion date of July 23, 2025. The contract was awarded without a set-aside designation on July 18, 2025, indicating full and open competition. Performance will take place in Santa Clara, California, with funding provided by the Defense Logistics Agency's Medical Supply Chain division, which procures advanced medical technologies for federal healthcare systems, including the Department of Defense and Department of Veterans Affairs. This delivery order represents a continuation of Abbott Vascular's established role as a critical cardiovascular medical device supplier to federal agencies. The Aveir Leadless Pacemaker is an advanced cardiac implant technology that represents the company's broader portfolio of sophisticated cardiovascular solutions. Abbott Laboratories Inc. has demonstrated substantial federal procurement experience through multiple indefinite delivery contracts with the DLA and regional Veterans Integrated Service Networks, including a significant $117.1 million DLA contract for comprehensive cardiovascular procedural packages, positioning the company as a strategic partner in federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 7/18/25 |